Nephrocare Health Serv Limited (NEPHROPLUS)

Volume: 13,555Avg Vol 1W: 15,942Avg Vol 1M: 35,38752W Range:₹446₹769.75

₹737▼ 0.82%

Key Ratios

Market Cap₹7,525 Cr

Current Price₹737

Previous Close₹743.1

High / Low (52w)₹769.75 / ₹446

Volume13,555

Avg Vol (1W)15,942

Avg Vol (1M)35,387

Stock P/E—

Book Value₹556.3

Dividend Yield0%

ROE6.88%

ROA5.22%

Revenue (TTM)—

Revenue Growth33.5%

Profit Margin7.69%

Total Debt₹96 Cr

Shares Outstanding10 Cr

Face Value₹10

EPS (TTM)₹3.03

P/B1.02

Debt / Equity0.07

50 DMA₹595.36

200 DMA—

Day change-0.82%

Price Chart

₹737▲ 56.28% · 1Y

2025-12-17

2026-06-16

20-day avg volume: 32K shares

Pros

Quarterly Results

Metric	Mar 2026	Dec 2025	Sept 2025	Mar 2025	Dec 2024
Revenue	₹266 Cr	₹260 Cr	₹246 Cr	₹219 Cr	₹197 Cr
EBITDA	₹39 Cr	₹42 Cr	₹44 Cr	₹36 Cr	₹31 Cr
Net Profit	₹30 Cr	₹32 Cr	₹-9 Cr	₹25 Cr	₹20 Cr
EPS	2.96	3.35	-1.12	2.95	2.39

Profit & Loss (Annual)

Metric	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Revenue	₹770 Cr	₹575 Cr	₹443 Cr	₹327 Cr	₹290 Cr
EBITDA	₹108 Cr	₹53 Cr	₹8 Cr	₹-17 Cr	₹8 Cr
Net Profit	₹67 Cr	₹35 Cr	₹-12 Cr	₹-21 Cr	₹1 Cr
EPS	8.01	4.4	-67.95	-130.96	1.73

Balance Sheet

Metric	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Total Assets	₹996 Cr	₹806 Cr	₹666 Cr	₹571 Cr	₹428 Cr
Total Liabilities	₹412 Cr	₹392 Cr	₹278 Cr	₹175 Cr	₹169 Cr
Equity	₹584 Cr	₹414 Cr	₹389 Cr	₹396 Cr	₹259 Cr
Total Debt	₹96 Cr	₹123 Cr	₹81 Cr	₹65 Cr	₹68 Cr

Cash Flow

Metric	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Operating	₹136 Cr	₹80 Cr	₹7 Cr	₹19 Cr	₹18 Cr
Investing	₹-125 Cr	₹-51 Cr	₹-78 Cr	₹-129 Cr	₹-61 Cr
Financing	₹54 Cr	₹27 Cr	₹60 Cr	₹121 Cr	₹36 Cr
Free Cash Flow	₹136 Cr	₹80 Cr	₹7 Cr	₹19 Cr	₹18 Cr

Shareholding

Promoter 63.85% Institutions 18.58% Public 17.56%

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search